First Clinical Use of Orthofix’s Virtuos Lyograft

Orthofix Medical Inc. announced today the limited market release and first patient implant of the Virtuos Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures. This allograft is prepared by MTF Biologics through a proprietary process that preserves all biologic components necessary for bone healing within the graft. Virtuos is provided in a room-temperature, ready-to-use, moldable form.
 
“The Virtuos allograft is unique in the fact that it can be stored at room temperature and is ready to implant within two minutes of being hydrated,” said Tomas Ellis, M.D., a neurosurgeon at Baylor Scott and White Surgical Hospital in Fort Worth, Texas, who implanted the first patient. “This helps ensure we can always have an easy-to-use, moldable, complete bone graft on hand, and it streamlines the preparation and overall surgical procedure time.”
 
Virtuos offers significant logistical and cost-savings advantages to the hospital with improved shipping, storage and operating room efficiency. The room temperature shipment and storage of Virtuos eliminates the use of large quantities of dry ice, Styrofoam shippers and freezer storage, enabling flexible shipping options and reduced packaging, with the aim of a reduced carbon footprint.
 
The Virtuos Lyograft is a complementary addition to the line of biologics offered by Orthofix through its exclusive partnership with MTF Biologics including the Trinity Elite, Trinity Evolution, FiberFuse Advanced, and FiberFuse Strip allografts, AlloQuent structural allograft and the Legacy DBM. In addition to MTF Biologic solutions, Orthofix proudly markets and distributes the Opus BA bioactive bone graft, Opus Mg Set bone void filler, Opus osteoconductive matrix, and the O-Genesis graft delivery system. This portfolio gives surgeons the ability to select the best option to meet their procedural and patient needs.  

“The Virtuos Lyograft provided through our exclusive partnership with MTF Biologics is at the forefront of allograft technology,” said Orthofix President of Global Spine Kevin Kenny. “Processed through a proprietary preservation method, Virtuos provides the best of both worlds. It delivers a high-quality shelf-stable bone graft with the clinical performance and superior handling that clinicians desire, as well as streamlined logistics for storage and preparation for the hospital.”
 
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via sales representatives and distributors. 
 
MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. 
 
The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe.